Duke Antimicrobial Stewardship Outreach Network (DASON)
DASON Digest
The DASON Digest features engaging conversations with experts in infectious diseases and antimicrobial stewardship covering a variety of topics. New episodes of the Digest are published every other Friday. Subscribe to follow along with our latest content. For more information about DASON, please visit https://dason.medicine.duke.edu.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Ep.90 – It Goes On and On and On: Reviewing the new RCT for Continuous infusion vs. Intermittent infusion Beta-lactams 21.06.2024 31:42
In this exciting episode, Drs. Libby Dodds Ashley and Jeannette Bouchard are joined by Dr. Jason Roberts to discuss his two newly published articles in JAMA that help to answer the question: is there a difference between continuous and intermittent infusions of beta-lactam antibiotics, especially in the critically ill populations? The reviewed materials can be found here: https://dason.medicine.du...
Ep.89 – Infectious Disease Consultations: Can AI Really Replace Human Experts? 07.06.2024 22:01
In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison Dr. Angelina Davis talks to us about the use of AI in the management of bloodstream infections. The article reviewed can be found here: https://academic.oup.com/cid/article-abstract/78/4/825/7308526
Ep.88 – Is the debate back?: A retrospective study in patients with sepsis who received piperacillin-tazobactam vs. cefepime 24.05.2024 17:31
Episode Notes In this episode, Dr. Jeannette Bouchard discusses a newly published article in JAMA about the use of piperacillin-tazobactam and cefepime in sepsis. This episode also ties into a previous episode (#74) and we would recommend listening to both episodes! The article reviewed in this episode can be found here: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2818278 For...
Ep.87 – BCI(De-escalation): The Impact of Rapid Diagnostics and Stewardship Intervention on Treatment of Contaminated Blood Cultures 10.05.2024 23:20
Episode Notes In this episode, University of Kentucky Infectious Diseases Pharmacy Residents, Will Harris and Tyler Pitcock, review a recently published article evaluating the impact of the implementation of rapid blood culture identification technology and stewardship intervention on treatment of blood cultures contaminated with coagulase-negative staphylococci. The article reviewed in this episo...
Ep.86 – PEN-FAST and Furious: The efficacy of the PEN-FAST tool in de-labeling previously reported penicillin allergies 26.04.2024 26:47
Episode Notes In this episode, University of Kentucky PGY2 Infectious Diseases Pharmacy Residents, Will Harris and Tyler Pitcock, discuss the recently published article evaluating the efficacy of the clinical decision tool, PEN-FAST, in de-labeling patients with reported penicillin allergies with one of the authors and Duke University Hospital Infectious Diseases Physicians, Dr. Nick Turner. The a...
Ep.85 – The devil's in the defaults: the impact of eliminating default durations of therapy 12.04.2024 27:04
Episode Notes In this episode, Duke University Hospital Infectious Diseases Pharmacist Dr. Rebekah Wrenn and her resident, Amy Mackowiak, review Dr. Wrenn's recently published article evaluating the impact of default duration elimination on exposure to fluoroquinolone therapy. The article reviewed in today's episode can be found here: https://pubmed.ncbi.nlm.nih.gov/38347810/ For more information...
Ep.84 – Navigating the LAByrinth: Updates in Antibacterial Susceptibility Testing 05.04.2024 53:43
Episode Notes In this episode of the DASON Digest Podcast, one of our DASON Clinical Pharmacist Liaisons, Dr. Melissa Johnson, talks with Dr. Jim Lewis, ID Clinical Pharmacy Coordinator and Adjunct Associate Professor at Oregon Health & Science University Departments of Pharmacy and ID in Portland, Oregon. The material reviewed in today's podcast can be found here: https://clsi.org/standards/p...
Ep.83 – Incorporating Adverse Event Feedback Into Antibiotic Stewardship 15.03.2024 14:34
Episode Notes In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison Dr. April Dyer talks to us about how to incorporate adverse event feedback into antibiotic stewardship. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/38415083/ For more information about DASON, please visit: https://dason.medicine.duke.edu
Ep.82 – Optimizing the use of the GI Panel and strategies to improve appropriate testing 01.03.2024 18:45
Episode Notes In this episode, DASON Clinical Pharmacist Liaisons Drs. Jeannette Bouchard and Libby Dodds-Ashley walk us through the details of a recent article published in ASHE to assess the impact of a clinical decision support survey to improve GI Panel ordering appropriateness at a VA. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/38415090/ For more i...
Ep.81 – Which of Active vs Passive Response to Rapid Diagnostic Blood Culture Results 19.02.2024 14:22
Episode Notes In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison Dr. Angelina Davis talks to us about the use of active versus passive methods of responding to rapid diagnostic blood culture results. The article reviewed can be found here: https://pubmed.ncbi.nlm.nih.gov/36483427/ For more information about DASON, please visit: https://dason.medicine.duke.edu/
Ep.80 – Exploring the Microbiome: Pertinent details from a phase 1 study exploring omadacycline in healthy guts 02.02.2024 23:34
Episode Notes In this episode, DASON Clinical Pharmacist Liaison Dr. Jeannette Bouchard is joined by Dr. Kevin Garey, an adjunct professor at the University of Texas School of Public Health and senior author of the reviewed article. They walk us through the details of the microbiome effects oral omadacycline has versus oral vancomycin and what this might mean for the future of the treatment for C....
Ep.79 – It’s All in the Dose: High-dose oral beta-lactams for bacteremic UTIs due to Enterobacterales 19.01.2024 19:32
Episode Notes In this episode, DASON Clinical Pharmacist Liaisons Drs. Melissa Johnson and Jeannette Bouchard discuss an article from ASHE on high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection. The article reviewed can be found here: https://pubmed.ncbi.nlm.nih.gov/37771747/ F...
Ep.78 – Source Specific Sepsis Order Sets Lead to Improved Empiric Therapy in the ED 05.01.2024 10:46
Episode Notes In this episode, Dr. April Dyer, one of our DASON Clinical Pharmacist Liaisons, talks to us about source specific order sets leading to improved empiric therapy in the ED in a 200 bed hospital. The article reviewed in this episode can be found here: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofad677/7491622# To learn more about DASON, please visit: https://dason.m...
Ep.77 – Optimizing Outpatient Ordering 15.12.2023 29:06
Episode Notes In this episode, Drs. Bouchard, Dodds Ashley, and Perez review a large study tackling inappropriate antimicrobial use in the outpatient setting. The article reviewed in this episode can be found here: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofad585/7439469 For more information about DASON, please visit: https://dason.medicine.duke.edu
Ep.76 – Ending VAP: is vaporizing antibiotics the answer? 01.12.2023 20:06
Episode Notes In this episode, Drs. Libby Dodds Ashley and Jeannette Bouchard, two of our DASON Clinical Pharmacists, talk to us about bringing and end to VAP. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/37888914/ For more information about DASON, please visit: https://dason.medicine.duke.edu
Ep.75 – Febrile Podcast: Being a Stewie 20.11.2023 45:07
Episode Notes This week we would like to use the feed to share a great episode of Sara Dong's podcast "Febrile." Members of our DASON team and the Society for Healthcare Epidemiology of America's antimicrobial stewardship committee celebrate antibiotic awareness week by discussing stewardship teams and an example case.
Ep.74 – Neurotoxicity vs Nephrotoxicity: A Look at the Comparative Safety of Cefepime and Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection 03.11.2023 21:03
Episode Notes In this episode, Dr. April Dyer, one of the DASON Clinical Pharmacists, talks about cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/37837651/ For more information about DASON, please visit: https://dason.medicine.duke.edu
Ep.73 – Analyzing Antibiograms: Reassessing a major tool 20.10.2023 34:47
Episode Notes Drs. Perez, Hillenbrand and Mourad do a deep dive on how to best apply one of our most common stewardship tools. The article reviewed in this episode can be found here: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciad467/7240295 For more information about DASON, please visit: https://dason.medicine.duke.edu
Ep.72 – Hit me with your best shot! Tools to select the best empiric therapy in complicated UTIs 29.09.2023 18:05
Episode Notes In this episode of the DASON Digest Podcast, DASON Clinical Pharmacist Liaison Dr. Jeannette Bouchard talks to us about clinical risk scores to improve empiric antimicrobial selection for outpatient complicated urinary tract infections. The article reviewed in this episode can be found here: https://academic.oup.com/ofid/article/10/8/ofad319/7198038#413122181 For more information ab...
Ep.71 – Emphasizing Health Equity 15.09.2023 33:23
Episode Notes In this episode, Dr. Rey Perez chats with Drs. Rebekah Moehring and Libby Dodds Ashley about work done by the University of Pittsburgh using a weighted lottery to equitably allocate scarce supply of COVID-19 monoclonal antibody to patients. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/37656472/ For more information about DASON, please visit:...
Ep.70 – Can we FINALLY stop antibiotics in culture negative serious infections? 01.09.2023 20:39
Episode Notes In this episode of the DASON Digest Podcast, DASON Clinical Pharmacist Liaison Dr. Angelina Davis talks to us about the early discontinuation of antibiotics in patients admitted with clinically suspected serious infection but negative cultures. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/37449298/ For more information about DASON, please vi...
Ep.69 – Creating Impactful, Feasible, Actionable, and Measurable Stewardship Interventions 18.08.2023 18:26
Episode Notes In this episode of the DASON Digest Podcast, DASON Clinical Pharmacist Liaison Dr. April Dyer talks to us about improving the efficiency of antimicrobial stewardship action in acute care facilities. The article reviewed in this episode can be found here: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofad412/7234482 For more information about DASON, please visit: http...
Ep.68 – Don’t be so Negative! A Look at GN-BSI in the US 04.08.2023 27:11
Episode Notes Dr. Rey Perez chats with our newest DASON Clinical Pharmacist Liaison, Dr. Jeannette Bouchard, about the epidemiology of gram negative blood stream infections. The article reviewed in this episode can be found here: https://academic.oup.com/ofid/article/10/7/ofad265/7175984 For more information about DASON, please visit: https://dason.medicine.duke.edu
Ep.67 – Rx for Success: Tackling Penicillin Allergy De-Labelling in our Hospitals 21.07.2023 16:15
Episode Notes Dr. Melissa Johnson from DASON talks to us about removing incorrect penicillin allergy labels. There are lots of supplemental materials for this episode, and they can all be viewed on the episode's page on our website: https://dason.medicine.duke.edu/blog/rx-success-tackling-penicillin-allergy-de-labelling-our-hospitals The main article discussed today is: https://pubmed.ncbi.nlm.nih...
Ep.66 – The Necrotizing Soft Tissue Infection Conundrum: Vancomycin Plus Clindamycin vs. Linezolid 07.07.2023 15:25
Episode Notes In this episode, Dr. Angelina Davis talks to us about the use of clindamycin + vancomycin vs. linezolid for the treatment of necrotizing soft tissue infections. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/37351452/ For more information about DASON, please visit: https://dason.medicine.duke.edu
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.